SIG
MD icon

Stanford Investment Group’s Pediatrix Medical MD Stock Holding History

Stanford Investment Group’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-120
Closed -$8K – 398
2016
Q3 		$8K Buy
+120
New +$8.21K ﹤0.01% 340

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Stanford Investment Group's MD Position: Q4 2016 in Review

Stanford Investment Group sold out of Pediatrix Medical (MD) in Q4 2016, closing a stake of 120 shares — an estimated $8K sold.

Stanford Investment Group first reported a position in MD in Q3 2016 and held it in 1 quarter. The position peaked at $8K in Q3 2016. 383 funds tracked by Wall St. Rank hold MD as of Q4 2016.

  • Stanford Investment Group reported no remaining Pediatrix Medical position as of Q4 2016 after selling out during the quarter.
  • Stanford Investment Group sold 120 Pediatrix Medical shares in Q4 2016, an estimated $8K.
  • Stanford Investment Group first reported a position in Pediatrix Medical in Q3 2016 and held it in 1 quarter.
  • Stanford Investment Group's Pediatrix Medical position peaked at $8K in Q3 2016.
  • 383 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2016.

Based on Stanford Investment Group's 13F filing for Q4 2016, filed 2 Feb 2017.